In 2016, OSI Group was honored with the Globe of Honour Award. The company received the award due to the amount of care that it takes with managing risks that might effect the environment. The award ceremony took place in London, and the company was chosen from a field of 18 other companies that operate all over the globe. Before any of these companies made it to the final running, they had to pass a certain set of standards. Every company that made the running also had to have demonstrated excellent levels of environmental management at every level of its business.Lynda Armstrong OBE, Chair for the British Safety Council, was present during the award ceremony and congratulated OSI Group for receiving the award and expressed her happiness with the fact that more and more companies are elevating their environmental standards.
The CEO of the British Safety Council, Mike Robinson, was also present, and it was him who handed the award off to Kelly Grimwood, the Environmental Manager for Europe for OSI. This is not the first time that OSI Group has been given this award. The company also took home Globes of Honour in 2013 and 2015.OSI Group is an American company headquarter in Aurora, Illinois with a global customer base that offers its clients customized food solutions based on their specific needs. It runs on an entrepreneurial model and treats its employees like part of a larger family. OSI runs a sustainable supply chain and has its own kitchen where expert chefs work on menu options for different clientele.
With top-level food safety and quality assurance practices, the company is committed to continuing its record as a provider of foods that meet the standards of its clientele and their customers. OSI Group is headed up by its CEO, Sheldon Lavin, and its President, David McDonald, and both of them have worked with the company for many years. It operates in 18 countries and has more than 60 facilities in locations all over the globe. OSI offers a spread of different foods to its variety of customers, and some of what it provides includes beef patties, sausage links, poultry, pizza, sandwiches, and convenience and snack foods. OSI Group plans to continue its expansion and pledges to continue serving its clientele in a way that sets them up for success.
Fabletics has become very dominant in a market that has long been dominated by large corporations such as Amazon. Fabletics did not use the usual “pop up” method to grow but instead grew gradually and got a really good feel for the market and its customers before scaling.
Fabletics is a subscription company and relies on information collected from those customers to personalize and customize their styles and clothing line. Fabletics encourages new members to take the Lifestyle Quiz in order to find out what it is that they like to do, what they like to wear, and what they want out of their athleisure wear.
For far too long brands have been defined by their price and typically more expensive brands are thought to be of much better quality. Fabletics has blasted this aged concept out of the water. Their athleisure brand is not only stylish, but affordable as well so their customers don’t have to break the bank to look good.
According to Gregg Throgmartin, the General Manager of Fabletics, the strategy of Fabletics is what has helped them to grow so well while still keeping their customers happy. Fabletics has been able to open stores in Florida, California, Illinois, and even Hawaii, and they plan to add many more as well.
The secret? To stay in touch with the customer and to provide personalized service while offering styles and quality that is still affordable. It is important to know what the customer wants in order to give them what they want.
Fabletics has used a technique known as “reverse showrooming” in order to become successful. While their competition is getting affected negatively by showrooming, Fabletics has sidestepped this problem. Fabletics avoided growing too rapidly and instead has taken the time to get to really know their customers through research. They encourage new members to take the Lifestyle Quiz, and that information is very valuable. They were able to find out exactly what the customer is after and design their clothing line around what they found out.
This resulted in about 30 to 50 percent of their customers shopping in-store already being members and another 25 percent normally signup to join the Fabletics club. Whatever a member decides to buy, and where they buy it, if it goes in the cart it counts towards their monthly membership cost. That means that members can shop online or in-store and it all counts towards their purchases.
As co-founder of Chicago’s Tempus Labs, Eric Lefkofsky has been at the helm of one of the most innovative healthcare start ups in the country for the past three years. To date, Tempus Labs has raised over $100 million in funding since its founding. Though it’s still a new venture, this company is currently valued at about $700 million.
Tempus Labs harnesses the power of big data and applies it to cancer treatments. So far, the technologies used by Tempus have made an impact when it comes to gene editing and gene therapies. Tempus believes that it may be more effective to treat cancers based on their profiles than on the way they spread. The hope is that by profiling each cancer, treatment can be tailored to a specific patient. With such targeting, the Tempus team believes doctors may see greater success rates.
Tempus doesn’t do the treatment, of course. It just does the analysis. But that is the revolutionary part of the process. Sequencing DNA and RNA was, in the past, an arduous task that could take years. With the arrival of Big Data, it has become much more efficient. Instead of following the cancer as it grows and spreads, the idea is to nip it in the bud as much as possible.
Recently, the Tempus team has been working on a number of projects. These include partnering with Stanford University scientists to learn more about skin cancers. An analysis of a rare vision disorder caused by genetic mutations has also been conducted, and may well play a role in FDA approval of a new treatment.
The Tempus team is comprised of both computer specialists and biological scientists. Immunologists, geneticists and others are able to assist with interpreting the data aggregated by engineers and data scientists. Together, these professionals are hoping to make real changes to the way oncologists work.